MicroPort CardioFlow Medtech Corporation (2160.HK) Comparison with companies in other sectors?

MicroPort CardioFlow Medtech Corporation has a share price of 2.41B. You can analyze MicroPort CardioFlow Medtech Corporation (2160.HK) competitors across different market sectors through stock heatmaps.

What are 2160.HK's NET and operating margins?

MicroPort CardioFlow Medtech Corporation (2160.HK) operating margin is around -0.17, and net profit margin is approximately -0.14 as of the latest reports.

In what way does 2160.HK's earnings per share (EPS) trend reflect its financial momentum?

MicroPort CardioFlow Medtech Corporation (2160.HK) EPS is -0.02 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for MicroPort CardioFlow Medtech Corporation is -64.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for MicroPort CardioFlow Medtech Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for MicroPort CardioFlow Medtech Corporation like P/E which is -55.18, P/B which is 1.25, and PEG which is -0.71. Compare them with sector averages to evaluate if the stock is priced fairly.

MicroPort CardioFlow Medtech Corporation

2160.HK•HKSE

Healthcare

Medical - Devices

HK$1.31

HK$0.02(1.55%)

MicroPort CardioFlow Medtech Corporation (2160.HK) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.02

P/E Ratio

-64.00

ROE

-0.02%

Net Margin

-0.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$3.09B

Shares OutstandingTotal number of shares issued

$2.41B

Book Value/ShareNet worth per share

$0.95

Revenue/ShareAnnual revenue per share

$0.16

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.02

Net MarginNet income as percentage of revenue

-13.68%

Operating MarginOperating income as percentage of revenue

-17.32%

ROEReturn on shareholders' equity

-2.27%

ROAReturn on total assets

-1.85%

ROCEReturn on capital employed

-2.79%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.04

Cash/ShareCash and equivalents per share

$0.58

FCF YieldFree cash flow as percentage of market cap

-3.20%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 2160.HKFinancial Ratios Analysis details for 2160.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 2160.HKSector Benchmarking details for 2160.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for MicroPort CardioFlow Medtech Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of MicroPort CardioFlow Medtech Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account MicroPort CardioFlow Medtech Corporation's unique business strengths and challenges.

Key Financial Metrics for MicroPort CardioFlow Medtech Corporation

For MicroPort CardioFlow Medtech Corporation, essential financial indicators include EPS -0.02, PE -64.00, and ROE -0.02. These key ratios reveal insights into MicroPort CardioFlow Medtech Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare MicroPort CardioFlow Medtech Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of MicroPort CardioFlow Medtech Corporation

Metrics like Net Margin -13.68% and ROA -1.85% shed light on how well MicroPort CardioFlow Medtech Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether MicroPort CardioFlow Medtech Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of MicroPort CardioFlow Medtech Corporation

Using ratios such as P/B Ratio 1.25 and PEG Ratio -0.71, investors can assess whether MicroPort CardioFlow Medtech Corporation is appropriately valued based on its financials and growth potential. These figures, combined with MicroPort CardioFlow Medtech Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for MicroPort CardioFlow Medtech Corporation

Financial health indicators, such as Debt/Equity Ratio 0.04 and Cash Flow $-0.04, provide a snapshot of MicroPort CardioFlow Medtech Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like MicroPort CardioFlow Medtech Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for MicroPort CardioFlow Medtech Corporation

Investing in MicroPort CardioFlow Medtech Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at MicroPort CardioFlow Medtech Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;